Interleukin 8 targeted contrast echocardiography is effective to evaluate myocardial ischemia-reperfusion injury in the rabbits

• Published in: Biomedicine & pharmacotherapy 2019-01, Vol.109, p.1346-1350
• Main Authors: Sun, Yue, Wang, Yuxue, Yang, Hanning, Lu, Yongping, Zhu, Guimin, Yang, Lihong, Zhao, Yifan, Hu, Bing, Ying, Tao
• Format: Article
• Language: English
• Subjects: Animals; Contrast echocardiography; Contrast Media - metabolism; Echocardiography - methods; Interleukin-8; Interleukin-8 - metabolism; Male; Microbubbles; Myocardial Infarction - metabolism; Myocardial ischemia; Myocardial Ischemia - metabolism; Myocardial Reperfusion - methods; Myocardial Reperfusion Injury - metabolism; Myocardium - metabolism; Rabbits; Reperfusion injury
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2018.10.126

Interleukin 8 (IL-8) is an important pro-inflammatory cytokine that recruits neutrophil to the areas of inflammation and has been implicated in myocardial ischemia reperfusion injury (MIRI). This study aimed to apply IL-8 targeted myocardial contrast echocardiography (MCE) to evaluate MIRI in rabbits. MCE imaging with IL-8 targeted microbubbles (MBIL-8) and control microbubbles (MBc) was performed in 40 Japanese white rabbits after brief proximal left anterior descending (LAD) partial occlusion for 30 min and subsequent reperfusion for 30 min, 60 min, 120 min and 180 min. Electrocardiogram and regional wall motion were assessed during occlusion and reperfusion. MCE demonstrated that IL-8 level rapidly increased in reperfused myocardial tissue and reached the peak after 120 min of reperfusion and lasted to 180 min of reperfusion. ELISA showed that the tendency of MCE data to change with reperfusion time was the same as that of IL-8 content. Taken together, these results suggest that targeted MCE with IL-8 antibody provides a new approach to noninvasive evaluation of MIRI using ultrasound imaging techniques.